The Defying Osteosarcoma TeamLab is studying osteosarcoma in dogs and people with the goal of uncovering breakthrough treatments for this deadly disease.

With seed funding support, The Osteosarcoma Institute is bringing two research teams together to better understand the biology of osteosarcoma and find new treatment solutions.

With clinical trials, new treatments move from research to real life. Here is how to decide if they are right for you.

The workshop opened new possibilities for smarter trial designs to advance development of innovative treatments, and forge stronger partnerships between regulators and industry.

Christina Curtis, PhD, MSc, a leader in cancer genomics at Stanford University, is applying her AI-driven research approaches that advanced breast cancer understanding to uncover osteosarcoma’s origins and new perspectives on therapy.

Advances in genetic sequencing and unprecedented collaboration among research institutions are helping scientists better predict prognosis, track treatment response, and move closer to personalized therapies for osteosarcoma.